Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00967915 · ClinicalTrials.gov registry record · NA
Efficacy of Neonatal Release of Ankyloglossia
A NA study, sponsored by United States Naval Medical Center, Portsmouth.
- Completed
- Registry status
- NA
- Development phase
- 58
- Enrollment target
NCT00967915: Completed NA study, sponsored by United States Naval Medical Center, Portsmouth.
NCT00967915 is a NA study that has completed, run by United States Naval Medical Center, Portsmouth. The registered enrollment target is 58 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00967915, a NA study, has completed, sponsored by United States Naval Medical Center, Portsmouth.
- COMPLETED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if frenotomy for ankyloglossia will improve infant breastfeeding, decrease maternal nipple pain and increase duration of breastfeeding with the hypothesis that frenotomy will do all of the above.
Interventions
- OTHER Sham procedure
- PROCEDURE Frentomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2007-11 |
| Est. Completion | 2009-07 |
| Phase | NA |
What the finished NCT00967915 record still lists
NCT00967915 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 58 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Sham procedure is the first listed.
NCT00967915 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00967915 about?
NCT00967915 is a clinical study titled "Efficacy of Neonatal Release of Ankyloglossia". The purpose of this study is to determine if frenotomy for ankyloglossia will improve infant breastfeeding, decrease maternal nipple pain and increase duration of breastfeeding with the hypothesis that frenotomy will do all of the above.
What is the current status of trial NCT00967915?
This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2007-11. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00967915?
The interventions under investigation include: Sham procedure (OTHER), Frentomy (PROCEDURE).
Who is sponsoring clinical trial NCT00967915?
This trial is sponsored by United States Naval Medical Center, Portsmouth, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00967915's enrollment target sits among peer trials
58 1256th of 2000 higher than 740 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia